GODAVARIB Godavari Biorefineries Q4 FY26 results (Jan–Mar 2026) and concall
Godavari Biorefineries delivered a resilient Q4 and FY26 performance, marked by a 6% increase in FY26 total income to INR2,000 crores and a 15.8% rise in EBITDA to INR139 crores. The company achieved a significant turnaround in profitability with a PAT of INR3.5 crores for FY26, recovering from a loss in the prior year. Strategic initiatives, including a 32% reduction in finance costs and progress on the 200 KLPD grain-based distillery, position the company for continued growth in bio-based solutions despite external challenges.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 2.8%, net profit down 26.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 321 | 447 | 580 | 533 | 431 +34% | 460 +3% | 564 −3% |
| EBITDA | -33 | 36 | 112 | 6 | -8 +76% | 43 +19% | 86 −23% |
| Net profit | -75 | 6 | 72 | -16 | -42 +44% | 8 +33% | 53 −26% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
